Improving cholesterol control after narrowing in brain arteries
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at strategies to improve cholesterol treatment in adults whose brain arteries are narrowed and who have had symptoms. Better cholesterol management may help reduce future problems related to this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have moderate to severe narrowing in brain arteries that has caused symptoms, and you did not have procedures like clot-busting medicine, thrombectomy, or stenting inside the blood vessel.
- Your LDL (“bad cholesterol”) is higher than 70 mg/dL (1.8 mmol/L).
- You are able and willing to have MRI brain scans (often 3T) so the blood vessels can be measured for the study.
- A clinician has told you that a statin (cholesterol-lowering medicine) is recommended for you.
- You can sign the study consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a PCSK9 inhibitor to standard statin therapy can help people with narrowing in brain arteries that hasn't caused symptoms yet. The goal is to see if this combination lowers plaque and prevents future strokes.
This study records outcomes for people with significant narrowing in brain arteries who have treatment using a drug-eluting stent. It may help doctors understand how well this approach works and what risks or benefits to expect.
This study enrolls people age 40 or older who have at least 50% narrowing in one brain or neck (carotid) artery. It collects clinical information to better understand this condition and how patients are doing over time.
This trial tests whether a cholesterol-lowering medication (PCSK9 inhibitor) can help prevent further strokes in people who have recently had a stroke or mini-stroke due to a narrowed artery in the brain. It is for adults 30 to 80 years old who meet specific health criteria.
This study tests whether combining a digital brain-training program with strong cholesterol-lowering medication can help improve thinking and memory in people with narrowing of arteries inside the brain. The goal is to reduce stroke risk and cognitive decline.
This trial tests whether adding a PCSK9 inhibitor to a statin is better than a statin alone for people with mild-to-moderate narrowing of the carotid artery (the main artery in the neck). It looks at how well these treatments slow plaque buildup and prevent strokes.
Hear when a new Intracranial Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.